Literature DB >> 14506245

Platelet-derived growth factor (PDGF) receptor-alpha-activated c-Jun NH2-terminal kinase-1 is critical for PDGF-induced p21WAF1/CIP1 promoter activity independent of p53.

Jiuhong Yu1, Xu-Wen Liu, Hyeong-Reh Choi Kim.   

Abstract

Platelet-derived growth factor (PDGF) is a potent mitogen for mesenchymal cells. PDGF AA functions as a "competent factor" that stimulates cell cycle entry but requires additional (progression) factors in serum to transit the cell cycle beyond the G1/S checkpoint. Unlike PDGF AA, PDGF B-chain (c-sis) homodimer (PDGF BB) and its viral counterpart v-sis can serve as both competent and progression factors. PDGF BB activates alpha- and beta-receptor subunits (alpha-PDGFR and beta-PDGFR) and induces phenotypic transformation in NIH 3T3 cells, whereas PDGF AA activates alpha-PDGFR only and fails to induce transformation. We showed previously that alpha-PDGFR antagonizes beta-PDGFR-mediated transformation through activation of stress-activated protein kinase-1/c-Jun NH2-terminal kinase-1, whereas both alpha-PDGFR and beta-PDGFR induce mitogenic signals. These studies revealed a striking feature of PDGF signaling; the specificity and the strength of the PDGF growth signal is modulated by alpha-PDGFR-mediated simultaneous activation of growth stimulatory and inhibitory signals, whereas beta-PDGFR mainly induces a growth-promoting signal. Here we demonstrate that PDGF BB activation of beta-PDGFR alone results in more efficient cell cycle transition from G1 to S phase than PDGF BB activation of both alpha-PDGFR and beta-PDGFR. PDGF AA activation of alpha-PDGFR or PDGF BB activation of both alpha- and beta-PDGFRs up-regulates expression of p21WAF1/CIP1, an inhibitor of cell cycle-dependent kinases and a downstream mediator of the tumor suppressor gene product p53. However, beta-PDGFR activation alone fails to induce p21WAF1/CIP1 expression. We also demonstrate that alpha-PDGFR-activated JNK-1 is a critical signaling component for PDGF induction of p21WAF1/CIP1 promoter activity. The ability of PDGF/JNK-1 to induce p21WAF1/CIP1 promoter activity is independent of p53, although the overall p21WAF1/CIP1 promoter activities are greatly reduced in the absence of p53. These results provide a molecular basis for differential regulation of the cell cycle and transformation by alpha- and beta-PDGFRs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506245     DOI: 10.1074/jbc.M309986200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-beta degrading enzyme neprilysin.

Authors:  Yvonne S Eisele; Matthias Baumann; Bert Klebl; Christina Nordhammer; Mathias Jucker; Ellen Kilger
Journal:  Mol Biol Cell       Date:  2007-07-11       Impact factor: 4.138

2.  Stromal platelet-derived growth factor receptor α (PDGFRα) provides a therapeutic target independent of tumor cell PDGFRα expression in lung cancer xenografts.

Authors:  David E Gerber; Puja Gupta; Michael T Dellinger; Jason E Toombs; Michael Peyton; Inga Duignan; Jennifer Malaby; Timothy Bailey; Colleen Burns; Rolf A Brekken; Nick Loizos
Journal:  Mol Cancer Ther       Date:  2012-08-28       Impact factor: 6.261

3.  PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms.

Authors:  Li Li; Donald K Blumenthal; Christi M Terry; Yuxia He; Mary L Carlson; Alfred K Cheung
Journal:  J Cell Biochem       Date:  2011-01       Impact factor: 4.429

Review 4.  Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications.

Authors:  Xiangyu Kong; Lei Li; Zhaoshen Li; Keping Xie
Journal:  Cytokine Growth Factor Rev       Date:  2012-07-01       Impact factor: 7.638

5.  Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylation.

Authors:  Qiwei Yang; Ziyan Lu; Ramaswamy Ramchandran; Lawrence D Longo; J Usha Raj
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-10-05       Impact factor: 5.464

6.  Platelet-derived growth factor-receptor alpha strongly inhibits melanoma growth in vitro and in vivo.

Authors:  Debora Faraone; Maria Simona Aguzzi; Gabriele Toietta; Angelo M Facchiano; Francesco Facchiano; Alessandra Magenta; Fabio Martelli; Silvia Truffa; Eleonora Cesareo; Domenico Ribatti; Maurizio C Capogrossi; Antonio Facchiano
Journal:  Neoplasia       Date:  2009-08       Impact factor: 5.715

Review 7.  JNK Signaling in the Control of the Tumor-Initiating Capacity Associated with Cancer Stem Cells.

Authors:  Chifumi Kitanaka; Atsushi Sato; Masashi Okada
Journal:  Genes Cancer       Date:  2013-09

8.  Pancreatic cancer stromal biology and therapy.

Authors:  Dacheng Xie; Keping Xie
Journal:  Genes Dis       Date:  2015-06-01

Review 9.  Epigenetically Mediated Ciliogenesis and Cell Cycle Regulation, and Their Translational Potential.

Authors:  Linda Xiaoyan Li; Xiaogang Li
Journal:  Cells       Date:  2021-07-02       Impact factor: 7.666

10.  Systems analysis of the prostate tumor suppressor NKX3.1 supports roles in DNA repair and luminal cell differentiation.

Authors:  Chih-Cheng Yang; Alicia Chung; Chia-Yu Ku; Laurence M Brill; Roy Williams; Dieter A Wolf
Journal:  F1000Res       Date:  2014-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.